Bafna Pharmaceuticals Ltd

Stage 2 · Advancing · week 18Setup 8.6 ★★★ PrimeStrong +13.2

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. More about the company

₹409.9
+1.99% today
₹970 Cr · Small cap
Market Neutral — FadingHealth Care 45.1% in Stage 2-2.0 pts / 20dPharmaceuticals 52.1%+1.3 pts
Loading price chart…
vs 52W High
0.0%
₹99.2 lo₹409.9 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 18
1w13w26w
Week 18 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
121.4%
200 DMA: ₹185.1 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.05x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +12.7% vs MA50 +19.3%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+35.8%
3M
+104.3%
6M
+258.9%
YTD
+160.8%
1Y
+137.2%
Sector
Health Care
↓ Peaking
Stage 2%
45.1%
20d Δ
-2.0pp
1M return
-5.0%
3M return
+0.2%
Sector Stage-2 % · last 20 days
This stock ranks #6 of 75 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
↑ Building
Stage 2%
52.1%
20d Δ
+1.3pp
1M return
-4.1%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Ranks #6 of 59 Stage 2 stocks in this industry. Top tier.
Stage Cycle Timeline2023-07-12 → 2026-10-08
S4 17w
S4 20w
S2 22w
S2 17w
2023-07-122026-10-08
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 4w → S3 5w → S4 12w → S1 5w → S2 6w → S3 1w → S4 11w → S1 6w → S4 11w → S1 2w → S4 17w → S1 4w → S4 20w → S1 2w → S2 22w → S3 12w → S4 5w → S1 7w → S2 17w current
Total tracked: 168 weeks across 19 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-08
Pullback Hunter
Latest: 2026-08-21
60 appearances in last 60 days. First seen: 2026-07-29.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-08S2
Wk 18 · Vol 0.05x
2026-10-07S2
Wk 17 · Vol 0.05x
2026-10-06S2
Wk 17 · Vol 0.02x
2026-10-05S2
Wk 17 · Vol 0.06x
2026-10-01S2
Wk 17 · Vol 0.02x
2026-09-30S2
Wk 17 · Vol 0.03x
2026-09-29S2
Wk 16 · Vol 0.23x
2026-09-28S2
Wk 16 · Vol 0.05x
2026-09-25S2
Wk 16 · Vol 0.10x
2026-09-24S2
Wk 16 · Vol 0.03x
2026-09-23S2
Wk 16 · Vol 0.03x
2026-09-22S2
Wk 15 · Vol 0.02x
Sector Peers — Stage 2All →
KILITCH
wk 2 · -6.3% from hi
8.3
SMSPHARMA
wk 3 · -7.6% from hi
8.3
RPGLIFE
wk 16 · -9.0% from hi
8.0
ZIMLAB
wk 21 · -4.1% from hi
7.9
SHILPAMED
wk 22 · -4.5% from hi
7.6
Moving averages & range
50 DMA
₹302.7
200 DMA
₹185.1
52W High
₹409.9
52W Low
₹99.2
5D Low
₹378.8
Resistance levels (recent highs)
20d High
₹409.9
60d High
₹409.9
120d High
₹409.9
250d High
₹409.9
Next resistance
Above all
Ask the Market AI about BAFNAPHAsk →
P/E (TTM)
31.8
Forward —
Earnings Growth (YoY)
+95.0%
Revenue +15.4%
About this companyHealth Care· Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-08. Past data patterns are not indicative of future results. This page is a data analytics tool only.